期刊文献+

过表达Plk-1对gemcitabine诱导的胰腺癌细胞化疗敏感性的影响

Overexpression of PlK-1 gene effects of PlK-1 gene on the chemotherapeutic sensitivity of pancreatic carcinoma cell line AsPC-1 response to gemcitabine
在线阅读 下载PDF
导出
摘要 目的观察Plk-1基因过表达对gemcitabine诱导胰腺癌细胞AsPC-1化疗敏感性的影响。方法①将携带有人外源性Plk-1基因的真核表达质粒转染AsPC-1细胞系设为处理组,转染空载体设为对照组,无处理组设为空白组,转染24 h后,提取细胞总RNA和总蛋白,利用RT-PCR法及Western blot鉴定AsPC-1细胞内Plk-1基因和蛋白表达水平。②采用流式细胞术检测转染组细胞凋亡的改变。③不同浓度gemcitabine作用于转染细胞,MTT法测定转染48 h后细胞增殖能力。结果①测序结果表明成功的从AsPC-1细胞总RNA中扩增Plk-1基因。RT-PCR结果表明:未转染组AsPC-1细胞组、转染空载体pcDNA3.1组及pcDNA3.1/Plk-1组24 h各组细胞内Plk-1 mRNA相对量分别为(2.14±0.16)、(2.18±0.15)、(2.58±0.18),转染pcDNA3.1/Plk-1组与其他各组相比,差异有高度统计学意义(P<0.01)。Western blot结果显示:未转染组AsPC-1细胞组、转染空载体pcDNA3.1及pcDNA3.1/Plk-1组24 h各组细胞内Plk-1基因的蛋白表达水平为(0.989±0.018)、(1.022±0.021)、(1.243±0.143),转染pcDNA3.1/Plk-1组与其他各组相比,差异有高度统计学意义(P<0.01)。②在gemcitabine作用下,pcDNA3.1/Plk-1转染组细胞凋亡率明显低于未转染组及空载体转染组,差异有高度统计学意义(P<0.01)。③AsPC-1/Plk-1转染组细胞的生长抑制率亦明显高于未转染组及空载体转染组,差异有高度统计学意义(P<0.01)。结论胞浆过表达Plk-1活性分子可明显降低gemcitabine诱导的AsPC-1细胞凋亡,增强其对化疗药物的耐受性。 Objective To investigate the effects of PlK-1 gene on the chemotherapeutic sensitivity of pancreatic carcinoma cell line AsPC-1 response to gemcitabine. Methods ①AsPC-1 cells transfected with Plk-1 overexpression plasmid(pcDNA/ Plk-1) was selected as treatment group,and empty vector(pcDNA3.1) was selected as control group,total RNA and total protein were extracted,AsPC-1 cells without any treatment was selected as blank group. The RT-PCR and western blotting assay were performed to detect the expression of Plk-1 gene and protein level in AsPC-1 cells after transfection with pcDNA/Plk-1 for 24 hours. ②Flow cytometry assay was used to detect the cell apoptosis change after treatment. ③MTT assays were used to test the effect of different concentration of gemcitabine on proliferation of transfected AsPC-1 cells. Results ①The expression level of Plk-1 mRNA in non-transfection AsPC-1 group,empty vector pcDNA3.1 transfection group and pcDNA3.1/Plk-1 transfection group were(2.14±0.16),(2.18±0.15),(2.58±0.18); the Plk-1 mRNA in pcDNA3.1/Plk-1 transfection group was higher than that in other groups,the differences were statistically significant(P 0.01). According to Western blot results,the protein expression level of Plk-1 in non-transfection AsPC-1 group,empty vector pcDNA3.1 transfection group and pcDNA3.1/Plk-1 transfection group were(0.989±0.018),(1.022±0.021),(1.243±0.143),the protein expression level of Plk-1 in pcDNA3.1/Plk-1 transfection group was higher than that in other groups,the differences were statistically significant(P 0.01). ②Under the function of Gemcitabine,apoptosis rate in pcDNA3.1/Plk-1 transfection group was lower than that in nontransfection group and empty vector transfection group,the differences were statistically significant(P 0.01). ③The inhibition proliferation rate of AsPC-1 cells of pcDNA3.1/ Plk-1 transfection group was higher than that of non-transfection group and empty vector transfection group,the differences was statistically significant(P 0.01). Conclusion Overexpression of Plk-1 gene in AsPC-1 cells can significantly decrease gemcitabine induced apoptosis and increase its chemotherapeutic resistentivity.
出处 《中国医药导报》 CAS 2013年第36期4-7,11,共5页 China Medical Herald
基金 国家自然科学基金面上项目(编号30972910 81172269) 中国博士后基金科学基金资助项目(编号20060390294) 江苏省自然科学基金项目(编号BK2011858)
关键词 Plk-1基因 耐药性 GEMCITABINE 胰腺癌 PlK-1 gene Chemoresistentivity Gemcitabine Pancreatic cancer
  • 相关文献

参考文献2

二级参考文献18

  • 1何冰,韩萍,吕先科.2型糖尿病患者急性时相蛋白与糖尿病肾病的关系[J].中华内分泌代谢杂志,2003,19(4):260-262. 被引量:170
  • 2夏育民,江珊,徐世正,丁国华,杨红霞.大黄素抑制IgG型抗双链DNA抗体诱导的系膜细胞表型转化的研究[J].中华风湿病学杂志,2007,11(5):271-274. 被引量:3
  • 3Li Y, Kang YS, Dai C, Kiss LP, Wen X, I.iu Y. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol. 2008, 172(2) : 299-308.
  • 4Li Y, Yang J, Dai C, Wu C, Liu Y. Role for integrinlinked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest. 2003; 112(4) : 503-516.
  • 5Willis BC, Borok Z. TGF-beta induced EMT mechanisms and implications for fibrotic lung disease Am J Physiol Lung Cell Mol Physiol. 2007, 293(3): L525-L534.
  • 6Yaswen L, Kulkarni AB, Fredrickson T, Mittleman B, Schiffman R, Payne S, Longeneeker G, Mozes E, Karlsson S. Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse. Blood. 1996; 87(4): 1439-1445.
  • 7Dai C, Stolz DB, Bastacky SI, St-Arnaud R, Wu C,Dedhar S, Liu Y. Essential role of integrin-linked kinase in podocyte biology: Bridging the integrin and slit diaphragm signaling. J Am Soc Nephrol. 2006; 17 (8) : 2164-2175.
  • 8Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis : pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol. 2004; 15(1): 1-12.
  • 9Yan Y, Su X, I.iang Y, Zhang J, Shi C, Lu Y, Gu L, Fu L. Emodin azide methyl anthraquinone derivative triggers mitochondrial dependent cell apoptosis involving in caspase-8-mediated Bid cleavage. Mol Cancer Ther. 2008; 7(6): 1688-1697.
  • 10Pickup JC,Mattock MB,Chusney GD,et al.NIDDM as a disease of the innate immune system:association of acute-phase reactants and interleukin-6 with metabolin syndrome X.Diabetologia,1997,40(11):1286-1292.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部